Last reviewed · How we verify
Pharmacokinetics blood samples
At a glance
| Generic name | Pharmacokinetics blood samples |
|---|---|
| Sponsor | Institut Claudius Regaud |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) (PHASE1)
- Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC) (NA)
- A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis (PHASE3)
- A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet (PHASE1)
- The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer (PHASE1)
- The Body's Affect on Vitamin C (PHASE1)
- Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI. (PHASE4)
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |